Gastric mucosal defense

Gastric mucosal defense is not a single molecule or receptor, but rather refers collectively to the complex set of anatomical structures and physiological processes that protect the stomach lining from its own acidic environment. This system includes: - A mucus-bicarbonate layer, which traps bicarbonate ions beneath a gel-like mucus layer secreted by specialized cells; this maintains near-neutral pH at the cell surface despite highly acidic luminal contents. - Epithelial cell integrity, including rapid turnover/restitution after injury. - Prostaglandins, which promote blood flow, stimulate mucus/bicarbonate production, and support tissue repair. - Adequate blood supply, essential for nutrient delivery and removal of noxious agents. Disruption in any component—by drugs like NSAIDs that inhibit prostaglandins, infections such as *Helicobacter pylori*, alcohol consumption, or other insults—can compromise this defensive system. This leads to increased risk for gastritis or peptic ulcer disease due to unopposed acid-mediated injury. Because it is not a discrete molecular target but rather an integrated physiological concept involving multiple molecules/cell types/processes—including ion channels/transporters (like H^+/K^+-ATPase), various receptors mediating protective signaling pathways (such as those responsive to acetylcholine/prostaglandins), structural proteins like different MUC-type glycoproteins—the term “gastric mucosal defense” should not be treated as a canonical drug target.

Other names

Gastric mucosal barrierGastric mucosa protectionMucosal defense mechanisms (stomach)

Drugs that interact with elements of gastric mucosal defense work by: - Stimulating mucus and bicarbonate secretion to reinforce the barrier - Directly protecting epithelial cells from acid injury (cytoprotection) - Promoting prostaglandin synthesis for increased blood flow and repair capacity